JPMorgan raises TransMedics target price to $85 from $73
TMDX•JPMorgan raised its target price for TransMedics Group to $85 from $73.
Related News
Nasdaq trade halt continues; reason not available at 3:58 a.m.
ONCO•
Jefferies raises Genpact target price to $50 from $45
G•
JPMorgan raises Bodycote voting rights to 10.004% from 9.828%
JPM•
Steven Madden, Ltd.: Jefferies raises to hold from underperform
SHOO•
Hanwha Investment & Securities plans KRW 5 billion equity-linked bond offering
MU•